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Renal Effect of Low-Dose
Dopamine in High-Risk
Patients Undergoing Coronary Angiography
Gare et al. (1) report no advantage of dopamine over “adequate
hydration” in patients with mild to moderate renal insufficiency
undergoing coronary angiography. The absence of a clinically
important effect is no surprise, for dopamine (2 mg/kg/min) would
not be a sufficient vasodilator to counteract such a potent renal
afferent arteriole vasoconstrictor as intrarenal adenosine. The
kidney responds to contrast media-induced osmotic stress with
afferent arteriolar vasoconstriction. This tubuloglomerular feed-
back response is largely mediated by adenosine, a mechanism that
has been confirmed by both animal and clinical studies (2–5). In
our randomized and blinded studies, the magnitude of adenosine
release and depression of creatinine clearance was proportional to
the osmolality of the contrast agent, essentially a dose-response
relation (2). It is attenuated by the adenosine receptor blocker
theophylline (3–5).
When pretreated with long-acting theophylline in addition to
hydration with D5W or half-normal saline, patients with moder-
ate renal dysfunction (creatinine #2.0 mg/dl) are reliably protected
from the nephrotoxic effects of contrast media (3–5). We currently
prescribe Theodur (3 mg/kg) orally the night before and b.i.d. the
day of angiography. It is critical that theophylline be administered
before contrast injection, but prolonged treatment after angiogra-
phy is unnecessary.
Theophylline prophylaxis to attenuate contrast-media nephro-
toxicity has not been adopted by cardiologists, perhaps because the
studies appeared in journals they do not normally read. Theoph-
ylline prophylaxis is effective, safe, and inexpensive. In view of the
magnitude of the clinical problem of contrast-media nephrotoxic-
ity, we wish to bring this therapeutic strategy to the attention of
the readers of JACC.
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REPLY
Thank you for your interest in our article on the renal effect of
low-dose dopamine in high-risk patients undergoing coronary
angiography (1). We found no important renal protective effect of
dopamine in patients at high risk for contrast nephropathy (CN)
undergoing coronary angiography. We agree that the vasodilator
effect of low-dose dopamine may be too small to counteract the
afferent arteriolar vasoconstriction induced by the contrast me-
dium. Higher doses of dopamine, however, may contribute to even
more severe vasoconstriction.
We have also been interested in the adenosine receptor blocking
effect of theophylline. We found that the acute renal failure
induced by indomethacin and contrast medium in rats with
diabetes mellitus (DM) was mediated by adenosine via suppression
of renal and/or systemic NO2
2/NO3 production and that theoph-
ylline reversed NO2
2/NO3 secretion to levels similar to those of
DM rats (2). The role of theophylline as a means of reducing CN
in the clinical setting, however, is not well defined. Although
Katholi (3) and Kolonko (4) have found some beneficial effect of
theophylline, more recent studies focusing on higher-risk patients
failed to demonstrate such effect. Abizaid et al. (5) found that
neither aminophylline nor dopamine reduced the incidence of CN
compared with saline hydration alone, in patients with serum
creatinine $1.5 mg/dl. Erley et al. (whose previous study was cited
by Katholi and Taylor in their present Letter to the Editor)
randomized 80 patients with serum creatinine $1.5 mg/dl to
either 810 mg of theophylline daily or placebo (6). They found that
hydration alone was sufficient to preserve glomerular filtration and
that theophylline had no additional benefit; they suggested that
theophylline might be beneficial in patients for whom sufficient
hydration is difficult, such as patients with severe congestive heart
failure (6). Such patients, however, are usually treated with
multiple medications, and adding theophylline at a sufficient dose
may be accompanied by intolerable side effects.
Therefore, it seems to us that the advantages of theophylline in
reducing the detrimental effect of contrast media, especially in
high-risk patients, have yet to be proven. The prevention of CN in
patients receiving contrast media should be based, at the present
time, on adequate hydration accompanied by diuresis when
needed.
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